Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Debt / NOTE 3.000%10/1
-
Unit price / market price
-
$0.8081
-
Total 13F principal
-
$91,657,126
-
Principal change
-
-$9,731,874
-
Total reported value
-
$83,984,443
-
Number of holders
-
9
-
Value change
-
-$1,736,501
-
Number of buys
-
3
-
Number of sells
-
5
Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 as of Q3 2022
As of 30 Sep 2022 KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 had 9 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $91,657,126 principal (par value or face value) of the bond of the company.
Largest 9 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, Davidson Kempner Capital Management LP, LAZARD ASSET MANAGEMENT LLC, Birch Grove Capital LP, CAPSTONE INVESTMENT ADVISORS, LLC, MACKAY SHIELDS LLC, Federation des caisses Desjardins du Quebec, BLB&B Advisors, LLC, and Context Capital Management, LLC.
This table shows 9 bond principal holders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.